IJGC Podcast

The International Journal of Gynecological Cancer (IJGC) podcast explores the latest research on detection, prevention, diagnosis, and treatment of gynecologic malignancies. Enjoy interviews with leading experts as they discuss novel and relevant topics in the field of gynecologic cancer. Join Editor-in-Chief Dr. Pedro Ramirez and his guests for an interactive and educational experience. Subscribe now or listen on your favourite podcast platform. IJGC - ijgc.bmj.com - is the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.

Listen on:

  • Apple Podcasts
  • Podbean App
  • Spotify
  • Amazon Music
  • TuneIn + Alexa
  • iHeartRadio
  • PlayerFM
  • Listen Notes
  • Podchaser
  • BoomPlay

Episodes

Tuesday May 26, 2020

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Jennifer Mueller to discuss genomic profiling of ultra-low risk endometrial cancer. Her article, "Clinical patterns and genomic profiling of recurrent ‘ultra-low risk’ endometrial cancer," (https://ijgc.bmj.com/content/early/2020/05/04/ijgc-2020-001241) is the lead article in the June 2020 issue of IJGC. Dr. Mueller is a gynecologic oncologist and assistant attending in the department of surgery at Memorial Sloan Kettering Cancer Center. She helps lead the endometrial cancer research team at MSKCC with an emphasis on prospective, translational and collaborative efforts within and across institutions.

Tuesday May 19, 2020

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Robert Coleman to for a summary discussion of the VELIA trial.

Friday May 08, 2020

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Terri L. Woodard to discuss fertility and ovarian function preservation in women with cancer. Dr. Woodard is a board-certified reproductive endocrinologist and infertility specialist with expertise in the field of oncofertility. She is the Founder and Director of the MD Anderson Oncofertility Program and holds a joint appointment as an Associate Professor in the Division of Reproductive Endocrinology and Infertility at Baylor College of Medicine.

Tuesday May 05, 2020

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Koji Matsuo to discuss cesarean radical hysterectomy outcomes. Cesarean radical hysterectomy is a rare surgical procedure and associated with increased risk of perioperative complication compared to open radical hysterectomy, particularly for hemorrhage.
Dr. Koji Matsuo is Associate Professor and Chief of the Oncology Research in the Division of Gynecologic Oncology at University of Southern California. Koji Matsuo, MD, PhD, is an Associate Professor in the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at the University of Southern California. Dr. Matsuo’s research focuses on outcomes research in gynecologic malignancies.

Tuesday Apr 28, 2020

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Yan Xiaojian to discuss open vs. MIS radical hysterectomy

Tuesday Apr 21, 2020

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Katherine Kurnit to discuss GI-based chemotherapy in ovarian mucinous cancers. Dr. Kurnit is an Assistant Professor at the University of Chicago in the section of Gynecologic Oncology. Her research interests include developmental therapeutics and early phase clinical trials for women with gynecologic malignancies.

Friday Apr 10, 2020

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Alexey Shevchuk to discuss the current state of gynecologic oncology in Russia. Dr. Shevchuk is a gynecologic oncologist in Moscow, Russia and engaged in collaborative partnerships with IGCS and the American Eurasian Cancer Alliance (AECA).

Tuesday Mar 31, 2020

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Lilie Lin to discuss radiotherapy and novel agents in gynecologic cancers. Dr. Lin is an Associate Professor in the Department of Radiation Oncology at the University of Texas, MD Anderson Cancer Center where she focuses on the management of gynecologic malignancies. She is the principal investigator of multiple clinical trials testing novel agents combined with radiotherapy for gyn malignancies; she is also interested in using novel PET radiotracers to interrogate the tumor microenvironment. Read her article, “Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin,” here: https://ijgc.bmj.com/content/early/2020/03/18/ijgc-2020-001227

Friday Mar 27, 2020

In this Podcast, our Editor-in-Chief, Dr. Pedro T Ramirez outlines the options for management of patients with gynecologic cancers during the global crisis of COVID-19.

Tuesday Mar 24, 2020

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Lea Moukarzel to discuss the ARIA Study and use of ICG in bowel surgery. Before starting her Gynecologic Oncology Fellowship at Memorial Sloan Kettering Cancer Center in 2018, Dr. Moukarzel completed her residency at Johns Hopkins Hospital. Dr. Moukarzel’s research involves the use of genomics and transcriptomics to investigate the genetic underpinning and immune microenvironment of gynecologic cancers as well as clinical work focused on improving surgical outcomes.

* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Copyright 2023 All rights reserved.

Version: 20241125